| 摘要 |
The present invention relates to a composition which is effective in preventing or treating irritable bowel syndrome by maintaining the stability of intestinal microbiota. The composition comprises Lactobacillus acidophilus LA1 (KCTC 11906BP), Lactobacillus rhamnosus LR5 (KCTC 12202BP), Bifidobacterium bifidum BF3 (KCTC 12199BP), Bifidobacterium animalis subsp. lactis BL3 (KCTC 11904BP), Bifidobacterium longum BG7 (KCTC 12200BP), and Streptococcus thermophilus ST3 (KCTC 11870BP) or cultures thereof as active ingredients. |
